ISSN: 1859 - 2872
Assessment of treatment in melasma by picosecond laser in 108 Military Central Hospital
Main Article Content
Keywords
Abstract
Objective: To evaluate the efficacy and safety of a picosecond laser (Picoplus, Lutronic, Korea) on patients with melasma. Subject and method: We conducted a comparative cross-sectional descriptive study in 58 melasma patients (100% females), middle-aged, with initial severe MASI underwent treatments in 108 Military Central Hospital from July 2017 to December 2018 with picosecond laser. Result: Before treatment the mean MASI score was 12.17 ± 4.43, mean treatment session was 9.05 ± 3.8 times. Good results 37.9%, fair results 48.3%. All most patient was no side effect, only 3.4% patients had temporary burning sensation. Conclusion: Treatment of melasma using a picosecond laser is an effective and safe method. However, the disadvantage of the method is the multistage procedure.
Keywords: Melasma, picosecond laser, picoplus.
Article Details
References
2. Esposito ACC, Brianezi G (2019) Ultrastructural characterization of damage in the basement membrane of facial melasma. Archives of Dermatological Research 312: 223–227.
3. Kimbrough-Green CK, Griffiths CE, Finkel LJ et al (1994) Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 130(6): 727-733.
4. Goh CL, Dlova CN (1999) A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J 40(7): 455-458.
5. Jagannathan, Manjula, Sadagopan, Kumaravel, Ekkarakudy, Jaleena et al (2017) Clinico-epidemiological study of patients with melasma in a Tertiary Care Hospital- A prospective study. International Journal of Scientific Study 4(11): 117-120.
6. Passeron T, Picardo M (2018) Melasma, a photoaging disorder. Pigment Cell Melanoma Res 31(4): 461-465.
7. Seleit I, Bakry OA, Masoud E et al (2017) Identification of genotypes and allelic frequencies of vitamin D receptor gene polymorphism (TaqI) in egyptian melasma patients. Indian Dermatol Online J 8(6): 443-448.
8. Lee YJ, Shin HJ, Noh TK et al (2017) Treatment of melasma and post-inflammatory hyperpigmentation by a picosecond 755-nm alexandrite laser in Asian patients. Ann Dermatol 29(6): 779-781.
9. Chalermchai T, Rummaneethorn P (2018) Effects of a fractional picosecond 1,064nm laser for the treatment of dermal and mixed type melasma. J Cosmet Laser Ther 20(3): 134-139.
10. Lacz NL, Vafaie J, Kihiczak NI et al (2004) Postinflammatory hyperpigmentation: A common but troubling condition. Int J Dermatol 43(5): 362-365.
Article Sidebar
